1Jorda M, Ganjei AP, Nadji M. Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry[J]. Arch Neurol, 1998,55 (2) : 181-184.
2Sze G, Soletsky S, Bronen R, et al. MR imaging of cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis[J]. A JR, 1989,153(5) : 1039-1049.
3OSchmann P, Kaps M, Volker J, et al. Meningeal carcinomatosis: CSF cytology, immunocytochemistry and biochemical tumor markers[J]. Acta Neurol Scand, 1994,89(5 ):395-399.
4Coakham HB, Garson JA, Brownell B, et al. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid[J]. Lancet, 1984,19(5) : 1095-1098.
5Crino PB, Sater RA ,Sperling M ,et al. Renal cell carcinomatosis meningitis: Pathologic and immunohistochemical features [J].Neurology, 1995,45(1 ) : 189-191.
6Castro MP,McDonald TJ,Qualman SJ ,et al. Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma[J ]. Cancer, 2001,91 (11 ) :2122-2126.
